Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Spiroboronic Esters. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.